- Home
- TWFG vs PACB Comparison
TWFG vs PACB Comparison
Compare TWFG & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWFG
- PACB
- Stock Information
- Founded
- TWFG 2001
- PACB 2000
- Country
- TWFG United States
- PACB United States
- Employees
- TWFG N/A
- PACB N/A
- Industry
- TWFG
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- TWFG
- PACB Industrials
- Exchange
- TWFG NYSE
- PACB Nasdaq
- Market Cap
- TWFG 468.4M
- PACB 452.1M
- IPO Year
- TWFG 2024
- PACB 2010
- Fundamental
- Price
- TWFG $33.04
- PACB $2.42
- Analyst Decision
- TWFG Buy
- PACB Buy
- Analyst Count
- TWFG 8
- PACB 15
- Target Price
- TWFG $27.86
- PACB $3.79
- AVG Volume (30 Days)
- TWFG 79.5K
- PACB 9.3M
- Earning Date
- TWFG 11-12-2024
- PACB 11-07-2024
- Dividend Yield
- TWFG N/A
- PACB N/A
- EPS Growth
- TWFG N/A
- PACB N/A
- EPS
- TWFG 40.85
- PACB N/A
- Revenue
- TWFG $187,281,000.00
- PACB $188,871,000.00
- Revenue This Year
- TWFG $18.16
- PACB N/A
- Revenue Next Year
- TWFG $18.73
- PACB $27.48
- P/E Ratio
- TWFG $0.82
- PACB N/A
- Revenue Growth
- TWFG 12.35
- PACB 29.24
- 52 Week Low
- TWFG $21.31
- PACB $1.16
- 52 Week High
- TWFG $34.34
- PACB $10.65
- Technical
- Relative Strength Index (RSI)
- TWFG N/A
- PACB 73.20
- Support Level
- TWFG N/A
- PACB $2.38
- Resistance Level
- TWFG N/A
- PACB $2.40
- Average True Range (ATR)
- TWFG 0.00
- PACB 0.20
- MACD
- TWFG 0.00
- PACB 0.07
- Stochastic Oscillator
- TWFG 0.00
- PACB 89.31
About TWFG TWFG INC
TWFG Inc is a independent distribution platform for personal and commercial insurance in the United States. It offers all lines of insurance, multiple distribution contract options, M&A services, proprietary virtual assistants, proprietary technology, proprietary premium financing, unlimited continuing education, recognition programs, co-op funding, marketing support and overall lower costs to operate.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.